Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-041837
Filing Date
2023-08-11
Accepted
2023-08-11 16:05:14
Documents
61
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q elox-20230630.htm   iXBRL 10-Q 2390321
2 EX-31.1 elox-ex31_1.htm EX-31.1 17608
3 EX-31.2 elox-ex31_2.htm EX-31.2 18802
4 EX-32.1 elox-ex32_1.htm EX-32.1 9393
5 EX-32.2 elox-ex32_2.htm EX-32.2 9553
  Complete submission text file 0000950170-23-041837.txt   7302394

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT elox-20230630_pre.xml EX-101.PRE 292256
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT elox-20230630_def.xml EX-101.DEF 141351
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT elox-20230630.xsd EX-101.SCH 50108
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT elox-20230630_lab.xml EX-101.LAB 391832
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT elox-20230630_cal.xml EX-101.CAL 52168
55 EXTRACTED XBRL INSTANCE DOCUMENT elox-20230630_htm.xml XML 1194047
Mailing Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472 781-577-5300
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

EIN.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31326 | Film No.: 231163982
SIC: 2836 Biological Products, (No Diagnostic Substances)